The FINANCIAL — London Stock Exchange on October 31 welcomes ConvaTec Group Plc, the UK headquartered, global medical products and technologies company to open trading following its successful IPO which capitalised the business at £4.39 billion.
The company, which raised £1.46 billion, is the largest European healthcare company to float in London since 1993 and is the 9th largest global healthcare IPO of all time, according to London Stock Exchange.
Nikhil Rathi, CEO, London Stock Exchange plc said:
“This landmark IPO demonstrates the enduring capacity of our capital markets to fund and support the growth and global ambitions of the UK’s leading manufacturers. Today is a further, powerful demonstration of the appeal of London’s unrivalled pool of international institutional investment capital.”
Paul Moraveic, CEO of ConvaTec Group Plc said:
“We are delighted to have successfully completed ConvaTec’s IPO in London. ConvaTec is a world leader in large, structurally growing markets for the management of chronic health conditions, and we have significant R&D and manufacturing operations in the UK. We are extremely pleased to welcome as shareholders high quality investors from the UK and internationally, and we look forward to life as a public company.”
